Saitta Cesare, Afari Jonathan A, Autorino Riccardo, Capitanio Umberto, Porpiglia Francesco, Amparore Daniele, Piramide Federico, Cerrato Clara, Meagher Margaret F, Noyes Sabrina L, Pandolfo Savio D, Buffi Nicolò M, Larcher Alessandro, Hakimi Kevin, Nguyen Mimi V, Puri Dhruv, Diana Pietro, Fasulo Vittorio, Saita Alberto, Lughezzani Giovanni, Casale Paolo, Antonelli Alessandro, Montorsi Francesco, Lane Brian R, Derweesh Ithaar H
University of California: San Diego Health System, San Diego, CA; Department of Urology, IRCCS Humanitas Clinical and Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
University of California: San Diego Health System, San Diego, CA.
Urol Oncol. 2023 Dec;41(12):487.e15-487.e23. doi: 10.1016/j.urolonc.2023.09.015. Epub 2023 Oct 23.
To create and validate 2 models called RENSAFE (RENalSAFEty) to predict postoperative acute kidney injury (AKI) and development of chronic kidney disease (CKD) stage 3b in patients undergoing partial (PN) or radical nephrectomy (RN) for kidney cancer.
Primary objective was to develop a predictive model for AKI (reduction >25% of preoperative eGFR) and de novo CKD≥3b (<45 ml/min/1.73m), through stepwise logistic regression. Secondary outcomes include elucidation of the relationship between AKI and de novo CKD≥3a (<60 ml/min/1.73m). Accuracy was tested with receiver operator characteristic area under the curve (AUC).
AKI occurred in 452/1,517 patients (29.8%) and CKD≥3b in 116/903 patients (12.8%). Logistic regression demonstrated male sex (OR = 1.3, P = 0.02), ASA score (OR = 1.3, P < 0.01), hypertension (OR = 1.6, P < 0.001), R.E.N.A.L. score (OR = 1.2, P < 0.001), preoperative eGFR<60 (OR = 1.8, P = 0.009), and RN (OR = 10.4, P < 0.0001) as predictors for AKI. Age (OR 1.0, P < 0.001), diabetes mellitus (OR 2.5, P < 0.001), preoperative eGFR <60 (OR 3.6, P < 0.001) and RN (OR 2.2, P < 0.01) were predictors for CKD≥3b. AUC for RENSAFE AKI was 0.80 and 0.76 for CKD≥3b. AKI was predictive for CKD≥3a (OR = 2.2, P < 0.001), but not CKD≥3b (P = 0.1). Using 21% threshold probability for AKI achieved sensitivity: 80.3%, specificity: 61.7% and negative predictive value (NPV): 88.1%. Using 8% cutoff for CKD≥3b achieved sensitivity: 75%, specificity: 65.7%, and NPV: 96%.
RENSAFE models utilizing perioperative variables that can predict AKI and CKD may help guide shared decision making. Impact of postsurgical AKI was limited to less severe CKD (eGFR<60 ml/min 71.73m). Confirmatory studies are requisite.
创建并验证2个名为RENSAFE(肾脏安全性)的模型,以预测接受肾癌部分肾切除术(PN)或根治性肾切除术(RN)患者术后急性肾损伤(AKI)及慢性肾脏病(CKD)3b期的发生情况。
主要目标是通过逐步逻辑回归开发一个预测AKI(术前估算肾小球滤过率[eGFR]降低>25%)和新发CKD≥3b(<45 ml/min/1.73m²)的模型。次要结局包括阐明AKI与新发CKD≥3a(<60 ml/min/1.73m²)之间的关系。通过曲线下面积(AUC)对接受者操作特征进行准确性测试。
1517例患者中有452例(29.8%)发生AKI,903例患者中有116例(12.8%)发生CKD≥3b。逻辑回归显示,男性(比值比[OR]=1.3,P=0.02)、美国麻醉医师协会(ASA)评分(OR=1.3,P<0.01)、高血压(OR=1.6,P<0.001)、RENAL评分(OR=1.2,P<0.001)、术前eGFR<60(OR=1.8,P=0.009)以及RN(OR=10.4,P<0.0001)是AKI的预测因素。年龄(OR 1.0,P<0.001)、糖尿病(OR 2.5,P<0.001)、术前eGFR<60(OR 3.6,P<0.001)以及RN(OR 2.2,P<0.01)是CKD≥3b的预测因素。RENSAFE AKI模型的AUC为0.80,CKD≥3b模型的AUC为0.76。AKI可预测CKD≥3a(OR=2.2,P<0.001),但不能预测CKD≥3b(P=0.1)。使用21%的AKI阈值概率时,灵敏度为80.3%,特异度为61.7%,阴性预测值(NPV)为88.1%。使用8%的CKD≥3b临界值时,灵敏度为75%,特异度为65.7%,NPV为96%。
利用围手术期变量预测AKI和CKD的RENSAFE模型可能有助于指导共同决策。术后AKI的影响仅限于较轻的CKD(eGFR<60 ml/min/1.73m²)。需要进行验证性研究。